Epidemiology and Biomarker Study in Alzheimer's Disease

Clinical trial NCT07142954 · RECRUITING

Trial details

NCT number: NCT07142954
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-08-25
Primary completion: 2033-07-01
Enrollment: 3400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.